Aquestive Therapeutics Inc. (AQST) Misses Q1 EPS by 8c

Aquestive Therapeutics Inc. (NASDAQ: AQST) reported Q1 EPS of ($0.24), $0.08 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $8.7 million versus the consensus estimate of $12.23 million.

For earnings history and earnings-related data on Aquestive Therapeutics Inc. (AQST) click here.

You May Also Be Interested In

• Lindsay (LNN) Tops Q3 EPS by 18c, Misses on Revenue
• Bassett Furniture Industries (BSET) Tops Q2 EPS by 1c, Misses on Revenue
• Green Bridge Metals gets drilling approval for Minnesota copper project